Trial site
L'Hospitalet de Llobregat
- 9running trials
- 12closed trials
The trials here
What the 21 trials at this site are about, from their registry records.
- Conditions
- Colorectal cancer3 trials
- Gastric and oesophageal cancer3 trials
- Lung cancer3 trials
- Metastatic breast cancer3 trials
- Multiple sclerosis3 trials
- Prostate cancer3 trials
- Coronary artery disease2 trials
- Melanoma2 trials
- Pancreatic cancer2 trials
- Stroke2 trials
- Chronic myeloid leukaemia1 trial
- Familial hypercholesterolaemia1 trial
- and 5 more
- Phase
- Phase 39 trials
- Phase 14 trials
- Phase 1/23 trials
- Phase 22 trials
- Phase 2/32 trials
- Status
- Completed9 trials
- Active, not recruiting6 trials
- Recruiting3 trials
- Terminated3 trials
- Lead sponsor
- Novartis Pharmaceuticals21 trials
Running trials
Active, not recruiting
Recruiting
Recruiting
Active, not recruiting
Recruiting
Active, not recruiting
Active, not recruiting
Study of JDQ443 in Patients With Advanced Solid Tumors Harboring the KRAS G12C Mutation
Active, not recruiting
Active, not recruiting
Long-term Safety, Tolerability and Effectiveness Study of Ofatumumab in Patients With Relapsing MS
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Multiple sclerosis1 recruiting
- Prostate cancer1 recruiting
Closed trials
Completed
Terminated
A Phase I Study of [177Lu]Lu-FF58 in Patients With Advanced Solid Tumors.
Completed
Completed
Study of Diagnostic Performance of [18F]CTT1057 for PSMA-positive Tumors Detection
Completed
Terminated
Completed
Completed
Completed
Terminated
Dose Finding Study of TNO155 in Adult Patients With Advanced Solid Tumors
Completed
Completed
A Study of LGK974 in Patients With Malignancies Dependent on Wnt Ligands
Site data: ClinicalTrials.govUpdated 17 Nov 2026